Comprehensive Analysis of Gene Signatures of m6ARNA Methylation Regulators in Lung Adenocarcinoma and Development of a Risk Scoring System
The recent application of targeted immunotherapy has greatly improved the clinical outcomes of patients with lung adenocarcinoma (LUAD), but drug resistance continues to emerge, and to evaluate and to improve patient prognosis are arduous. The diagnostic and prognostic value of N6-methyladenosine (M...
Saved in:
Main Authors: | Chundi Gao, Huayao Li, Wenzhe Ma, Qiming Zhang, Cun Liu, Lijuan Liu, Jing Zhuang, Changgang Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/7519838 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
molla fahrEttİn arnâSî’nİn İSaGocİ’Sİ*
by: Nazım Hasırcı
Published: (2012-11-01) -
A Cell Differentiation Trajectory-Related Signature for Predicting the Prognosis of Lung Adenocarcinoma
by: Fan Yang, et al.
Published: (2022-01-01) -
Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma
by: Juan Peng, et al.
Published: (2024-01-01) -
A prognostic signature of Glutathione metabolism-associated long non-coding RNAs for lung adenocarcinoma with immune microenvironment insights
by: Junxi Hu, et al.
Published: (2025-02-01) -
Oncogenic RIT1 mutations confer ferroptosis vulnerability in lung adenocarcinoma
by: Ruilan Ma, et al.
Published: (2025-02-01)